The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol
Chun-Jung Cho1,2, Ching-Wei Yang3, Chia-Lun Wu2
1Graduate Institute of Pathology and Parasitology, National Defense Medical Center, Taipei 114, Taiwan, R.O.C.
Abstract:
Gemcitabine (GCB), which functions via the inhibition of DNA synthesis, is commonly used in the treatment of bladder cancer; however, its response rate is not satisfactory due to the development of drug resistance. The potential for phytochemicals to reverse drug resistance in bladder cancer tumor cells was evaluated. A human bladder cancer cell line, T24, was cultured, and GCB-resistant cells (T24-GCB) were also established. The acquired resistance of T24-GCB to GCB was measured using an MTT assay. The gene expression of ATP-binding cassette (ABC) transporter protein family members was analyzed using reverse transcription-quantitative PCR analysis, and western blotting was performed to verify ABC family protein, cytoplasmic thymidine kinase (TK) and poly (ADP-ribose) polymerase (PARP) expression on whole cell lysates. Subsequently, resveratrol and curcumin were used to evaluate their modulation potential in decreasing the drug resistance of T24-GCB cells to GCB using MTT and migration assays. T24-GCB cells have increased drug resistance ability, with an 18.75-fold higher ID50 value compared with native T24 cells (105 vs. 5.6 nM). T24-GCB cells also exhibit increased cross resistance to mitomycin C and paclitaxel. The mRNA expression of ABCC2 in T24-GCB cells increased compared with that in native T24 cells. Via western blot analysis, it was determined that the expression of ABCC2 protein was also increased in T24-GCB cells. Conversely, the expression of ABCB1, ABCG2, deoxycytidine kinase (DCK), TK1 and TK2 decreased. Following curcumin and resveratrol treatment alone or combined with GCB, additive cytotoxic enhancement was observed, and the migratory abilities of T24-GCB cells were significantly decreased. Western blot analysis revealed that ABCC2 protein expression increased, and DCK, TK1 and TK2 expression decreased following co-treatment of T24-GCB cells with GCB + curcumin or resveratrol compared with GCB alone. Of note, there was a marked increase in cleaved-PARP expression in T24-GCB cells treated with a combination of GCB + curcumin or resveratrol. Both curcumin and resveratrol could reverse the drug resistance of T24-GCB cells in an additive pattern though PARP enhancement without changes in ABCC2 and DCK, TK1 and TK2 expression.
Insights
Phytochemicals like curcumin and resveratrol can reverse gemcitabine (GCB) resistance in bladder cancer cells. These compounds enhance GCB
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Gemcitabine (GCB) is a key chemotherapy for bladder cancer, but drug resistance limits its efficacy.
- Phytochemicals are being investigated for their potential to overcome chemotherapy resistance in cancer.
- Understanding the molecular mechanisms of GCB resistance is crucial for developing effective treatments.
Purpose of the Study:
- To evaluate the potential of phytochemicals, specifically resveratrol and curcumin, to reverse gemcitabine resistance in bladder cancer cells.
- To investigate the effects of these phytochemicals on drug resistance markers and cellular behavior.
Main Methods:
- Established gemcitabine-resistant T24 bladder cancer cells (T24-GCB).
- Assessed drug resistance using MTT assays and measured cross-resistance to other chemotherapeutics.
- Analyzed gene and protein expression of ATP-binding cassette (ABC) transporters, thymidine kinases (TKs), and poly (ADP-ribose) polymerase (PARP) using RT-qPCR and Western blotting.
- Evaluated the impact of curcumin and resveratrol, alone and with GCB, on cell viability and migration.
Main Results:
- T24-GCB cells exhibited significantly increased resistance to GCB (18.75-fold higher ID50) and cross-resistance to mitomycin C and paclitaxel.
- Elevated ABCC2 expression and decreased expression of ABCB1, ABCG2, deoxycytidine kinase (DCK), TK1, and TK2 were observed in T24-GCB cells.
- Curcumin and resveratrol, alone or combined with GCB, demonstrated additive cytotoxic effects and reduced cell migration.
- Co-treatment increased cleaved-PARP expression, indicating apoptosis, without altering ABCC2 and DCK, TK1, TK2 expression levels.
Conclusions:
- Resveratrol and curcumin can effectively reverse gemcitabine resistance in bladder cancer cells.
- These phytochemicals enhance GCB cytotoxicity and reduce cell migration, offering a potential strategy to improve bladder cancer treatment outcomes.
- The observed effects are associated with PARP activation, suggesting a role in overcoming drug resistance.
Related Concept Videos
Treatment Resistant Cancers
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Destabilize Microtubules


